Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Advanced Medicine

Business & Regulation Advanced Medicine

Let's Meet in the Middle

| Bill Milligan

As long as payers recognize the value of a curative treatment and manufacturers are flexible with payment plans, patients will have access to ATMPs.

Business & Regulation Advanced Medicine

Cell and Gene Pricing: How Can Manufacturers Get it Right?

| Ana Stojanovska

For manufacturers, educating stakeholders, generating evidence and putting the patient first are key to getting value based contracts right.

Business & Regulation Advanced Medicine

Advanced Therapies: The Price is Right?

| Dan Ollendorf

Are healthcare systems and manufacturers ready to embrace evidence-based pricing to lessen the impact of upfront costs of advanced therapies?

Business & Regulation Advanced Medicine

Building a Business: Lessons Learned with Angela Osborne

| Maryam Mahdi

Angela Osborne has created her own space in the industry and is helping the cell and gene therapy industry bloom.

Manufacture Advanced Medicine

NextGen Now: Delivering Tomorrow's Facilities Today

| Ryan McDonough

If cell and gene therapy products are to successfully reach patients, then the industry will need more facilities capable of manufacturing them.

Discovery & Development Advanced Medicine

Perusing the Pipeline

| James Strachan

With cell and gene therapies being all the rage, we take a peek at some of the advanced therapies coming down the pipe.

Business & Regulation Advanced Medicine

C&G Therapy? That’ll Do NICEly

| James Strachan

Nick Crabb explains the UK’s health technology assessment agency's (NICE's) approach to cell and gene therapies.

Manufacture Advanced Medicine

Living, Breathing Logistics

The supply of cell and gene therapies is a delicate operation – and easily broken, just like daisy chains.

Business & Regulation Drug Discovery

Here's to New Beginnings

| Stephanie Sutton

Conversations around drug pricing look set to continue for years, but the industry is also experiencing fantastic breakthroughs in science.

Manufacture Advanced Medicine

Trials of a Medicine Maker

What lies ahead for Gene and Eva in 2019? Cell and gene therapies!

Newsletter

Send me the latest from The Medicine Maker.

Sign up now

Latest White Papers

Early stage product development using laser diffraction analysis

| Contributed by Malvern Panalytical

Measurement of the concentration of Adeno-Associated Virus

| Contributed by Malvern Panalytical

All White Papers

Sister Publications

You might be interested in our Sister Publications:

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register